Please be advised, the article processing charges for Clinical Phytoscience are fully sponsored for all accepted articles by the Michael A. Popp nature science foundation.
For further details about this, please see our Fees and Funding page.
Clinical Phytoscience is an international, peer-reviewed, interdisciplinary, and open access journal publishing high quality research articles on clinical evidence and use of medicinal plants in the development of efficient and well tolerated phytotherapy.
Clinical Phytoscience focuses on phytotherapy, looking at proof of concept, efficacy and safety, to be established “at eye level” compared to pharmacotherapy. The emphasis lies on application oriented topics (efficacy and safety of phytotherapy in a specific indication, including its need and acceptance by the patient). The scientific results published in the journal should contribute to the recovery and maintenance of human health by phytotherapy.
Clinical Phytoscience will publish high-quality evidence-based clinical studies and relevant pharmacological studies. Key areas of interest are:
The journal publishes original contributions, review articles and short communications (letters). Articles are published after a rigorous and independent peer-review by an international board of experts. The journal is directed at medical doctors in clinic and practice and pharmacologists.
Clinical Phytoscience does not accept purely descriptive pre-clinical work without translational aspects for publication. All manuscripts need to include:
• Statistical analysis
• Titration of the extracts
• Repetition of experiments
• Validation in vivo
25 days submission to first editorial decision for all manuscripts (Median)
366 days submission to accept (Median)
149 Altmetric mentions